Combined cyclosporin-A and methylprednisolone treatment of Graves' ophthalmopathy.
Andras Leovey, Gyula Bakó, J Szabó, K Kálmán, Éva Fórizs
Abstract
Andras Leovey, Gyula Bakó, J Szabó, K Kálmán, Éva Fórizs
Abstract
Twelve patients with Graves' ophthalmopathy (grade 1-6, ATA classification) were treated with Cyclosporin-A, systemically in combination with methylprednisolone. We observed slight or moderate favourable effect in 9 cases. Our data suggest that the benefit was due to the methylprednisolone, the effectivity of which was enhanced by the cyclosporin even in the glucocorticoid-resistant cases.
OpenAlex reports 9 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Twelve patients with Graves' ophthalmopathy (grade 1-6, ATA classification) were treated with Cyclosporin-A, systemically in combination with methylprednisolone. We observed slight or moderate favourable effect in 9 cases. Our data suggest that the benefit was due to the methylprednisolone, the effectivity of which was enhanced by the cyclosporin even in the glucocorticoid-resistant cases.
Key concepts: Methylprednisolone, Graves' ophthalmopathy, Medicine, Glucocorticoid, Internal medicine, Dermatology, Graves' disease, Disease